UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial

A multi-institutional phase II trial was conducted to evaluate the efficacy and toxicity of combination chemotherapy consisting of gemcitabine and UFT, which is composed of tegafur and uracil, for non-small-cell lung cancer (NSCLC) patients. Patients with advanced NSCLC received an oral administrati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ichinose, Y, Seto, T, Semba, H, Itoh, K, Inoue, Y, Tanaka, F, Araki, J, Tamanoi, M, Yamamoto, H, Iwamoto, N
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2005
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361641/
https://ncbi.nlm.nih.gov/pubmed/16175186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602781
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki